[
    {
        "other_ids": [],
        "amendment_date": null,
        "keywords": [
            "Solid malignancy",
            "Lymphoma",
            "Solid tumor",
            "Melanoma",
            "Non-small cell lung cancer",
            "Epithelial ovarian carcinoma",
            "NSCLC",
            "EOC",
            "LXR",
            "ApoE",
            "Small cell lung cancer",
            "SCLC",
            "High-grade neuroendocrine tumors",
            "HG-NET"
        ],
        "dcp_id": null,
        "interventional_model": "Parallel",
        "lead_org": "Inspirna, Inc.",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "The patient must have histologic or cytologic evidence of a malignant solid tumor or lymphoma (any histology) and must have advanced disease, defined as cancer that is either metastatic or locally advanced and unresectable (and for which additional radiation therapy or other locoregional therapies are not considered feasible)."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "With the exception of dose escalation with pembrolizumab plus carboplatin/pemetrexed, patients enrolled in the dose escalation stages must have disease that is resistant to or relapsed following available standard systemic therapy, or for which there is no standard systemic therapy or reasonable therapy in the physician's judgment likely to result in clinical benefit or if such therapy has been refused by the patient. Documentation of the reason must be provided for patients who have not received a standard therapy likely to result in clinical benefit."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Patients enrolled in the expansion stages must agree to a tumor biopsy to be obtained during the screening period and toward the beginning of Cycle 2 or at the time of PD, if earlier. If a biopsy is deemed by the investigator to not be in the patient's best interest, prior approval must be obtained from the Medical Monitor to waive this requirement."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "The patient must have disease that is measurable by standard imaging techniques per RECIST or immune-related response criteria (irRC; all tumor types except lymphoma) or International Working Group (IWG) revised response criteria for malignant lymphoma (lymphoma only). For patients with prior radiation therapy, measurable lesions must be outside of any prior radiation field(s), unless disease progression has been documented at that disease site subsequent to radiation."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "The patient is \u226518 years old."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "The patient has an ECOG PS of \u22641."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "The patient has adequate baseline organ function, as demonstrated by the following:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Serum creatinine \u22641.5 \u00d7 institutional upper limit of normal (ULN) or calculated creatinine clearance >30 mL/min (>45 ml/min for patients receiving carboplatin/pemetrexed)."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Serum albumin \u22652.5 g/dl;"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Bilirubin \u22641.5 \u00d7 institutional ULN."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) \u22642.5 \u00d7 institutional ULN. Patients enrolled in an expansion stage may have ALT and AST < 5 \u00d7 institutional ULN if the patient has hepatic metastases;"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 11,
                    "description": "For patients not taking warfarin or other oral anticoagulants: international normalized ratio (INR) \u22641.5 or prothrombin time (PT) \u22641.5 \u00d7 ULN; and either partial thromboplastin time or activated partial thromboplastin time (PTT or aPTT) \u22641.5 \u00d7 ULN. Patients taking warfarin should be on a stable dose that results in a stable INR <3.5. Among patients receiving other oral anticoagulant therapy, PT or aPTT must be within the intended therapeutic range of the anticoagulant."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 12,
                    "description": "The patient has adequate baseline hematologic function, as demonstrated by the following:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 13,
                    "description": "Absolute neutrophil count (ANC) \u22651.5\u00d7109/L;"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 14,
                    "description": "Hemoglobin \u22658 g/dL and no red blood cell (RBC) transfusions during the prior 14 days;"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 15,
                    "description": "Platelet count \u2265100\u00d7109/L and no platelet transfusions during the prior 14 days."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 16,
                    "description": "The patient has a normal left ventricular ejection fraction (LVEF) per institutional criteria as determined by either echocardiography (ECHO) or multigated acquisition (MUGA) scanning."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 17,
                    "description": "If the patient is a woman of child-bearing potential (WOCBP), she has had a negative serum or urine pregnancy test within 2 weeks prior to treatment."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 18,
                    "description": "The patient (men and WOCBP) agrees to use acceptable contraceptive methods for the duration of time on the study, and continue to use acceptable contraceptive methods for 1 month after the last dose of study therapy. Patients receiving combination therapy must agree to use acceptable contraceptive methods for the duration of time on the study and continue to use acceptable contraceptive methods for 6 months after the last dose of study therapy."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 19,
                    "description": "The patient has signed informed consent prior to initiation of any study-specific procedures or treatment."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 20,
                    "description": "The patient is able to adhere to the study visit schedule and other protocol requirements, including follow-up for survival assessment."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 21,
                    "description": "Tumor tissue (a minimum of 10 and up to 15 unstained slides, or paraffin block, ideally from the patient's most recent biopsy, must be made available prior to the first dose of study therapy."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 22,
                    "description": "For patients with EOC enrolled in the single agent expansion stage:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 23,
                    "description": "The patient must have a pathologically confirmed (by histology or cytology) diagnosis of epithelial ovarian, fallopian tube or primary peritoneal carcinoma, which is currently recurrent or persistent Stage 3 or Stage 4 disease. A histologic diagnosis of borderline, low malignant potential epithelial carcinoma is not permitted."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 24,
                    "description": "The patient must have received an appropriate platinum-based chemotherapy in the first line setting."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 25,
                    "description": "If the patient has platinum-sensitive relapsed disease (first relapse > 6 months from end of initial platinum therapy), the patient should have been re-treated with platinum for relapsed disease (or be intolerant or have refused such treatment)."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 26,
                    "description": "The patient may not have received treatment with immune checkpoint inhibitors (e.g., products that target PD-L1, PD-1, or CTLA-4)."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 27,
                    "description": "The patient must not have required a paracentesis within the preceding 4 weeks nor be projected to require a paracentesis within the next 8 weeks."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 28,
                    "description": "For patients with NSCLC enrolled in the pembrolizumab plus carboplatin/pemetrexed combination dose escalation or expansion stages:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 29,
                    "description": "The patient must have histologic or cytologic evidence of newly-diagnosed non-squamous, NSCLC that is advanced disease, defined as cancer that is either metastatic (Stage 4) or locally advanced (Stage 3B) and unresectable."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 30,
                    "description": "The patient has confirmation that epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK)-directed therapy is not indicated."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 31,
                    "description": "The patient has not received prior systemic treatment for their advanced/metastatic disease."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 32,
                    "description": "For patients in the expansion stage only: the patient's tumor block must demonstrate PD-L1 expression TPS <1% as determined with a validated assay."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 33,
                    "description": "The patient must have adequate organ function and performance status eligible for treatment with a platinum-based regimen and checkpoint inhibitor."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 34,
                    "description": "For patients with SCLC enrolled in the docetaxel combination expansion stage:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 35,
                    "description": "The patient must have a pathologically confirmed (by histology or cytology) diagnosis of SCLC, which is currently extensive disease (disease outside a single radiation port), or of metastatic neuroendocrine cancer with small cell or high-grade features. Patients with metastatic neuroendocrine cancer with small cell or high-grade features must have a pathology report supplied to the sponsor before treatment."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 36,
                    "description": "The patient must have demonstrated disease progression following platinum-based chemotherapy with or without a PD-1/L1 inhibitor for SCLC, or following a different, acceptable first-line regimen for high-grade neuroendocrine tumors."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 37,
                    "description": "The patient must have received no more than 1 prior line of therapy for extensive disease."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 38,
                    "description": "The patient has persistent clinically significant toxicities (Grade \u22652) from previous anticancer therapy (excluding Grade 2 chemotherapy-related neuropathy and alopecia which are permitted). Prior toxicities that resulted in laboratory abnormalities should have resolved to Grade \u22641, unless a higher-grade abnormality is allowed by the inclusion criteria. If medical therapy is required for the treatment of a laboratory abnormality, the dose and laboratory value(s) should be stable."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 39,
                    "description": "If considered for combination therapy with nivolumab or ipilimumab, the patient has:"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 40,
                    "description": "Uncontrolled clinically significant pulmonary disease."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 41,
                    "description": "A history of any grade immune-related ocular event."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 42,
                    "description": "A history of Grade \u22653 immune-related adverse event regardless of offending agent."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 43,
                    "description": "Active autoimmune disease that required systemic treatment in the past. Patients who have not required systemic treatment for at least two years may be enrolled if permission is provided after discussion with the Medical Monitor (replacement therapy, e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, is not considered a form of systemic treatment, and is allowed)."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 44,
                    "description": "Evidence of active noninfectious pneumonitis or history of interstitial lung disease."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 45,
                    "description": "A risk of reactivation of hepatitis B or C."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 46,
                    "description": "Previously received an immune therapy that was discontinued due to immune-related AEs, regardless of grade."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 47,
                    "description": "Uncontrolled endocrine disorder. Patients who are on endocrine replacement therapy must be on a stable dose."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 48,
                    "description": "The patient has received treatment with chemotherapy, external-beam radiation, or other systemic anticancer therapy within 14 days prior to study therapy administration (42 days for prior nitrosourea or mitomycin-C; patients with advanced prostate cancer who are receiving luteinizing hormone releasing hormone (LHRH) agonists are permitted onto the study and should continue use of these agents during study treatment)."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 49,
                    "description": "The patient has received treatment with an investigational systemic anticancer agent within 14 days prior to study therapy administration."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 50,
                    "description": "The patient has previously received treatment with RGX-104 or another investigational agent that is a known LXR agonist."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 51,
                    "description": "The patient has an additional active malignancy that may confound the assessment of the study endpoints. Patients with a past cancer history with substantial potential for recurrence must be discussed with the Medical Monitor before study entry. Patients with the following concomitant neoplastic diagnoses are eligible: non-melanoma skin cancer, carcinoma in situ (including transitional cell carcinoma, cervical intraepithelial neoplasia, and melanoma in situ), organ-confined prostate cancer with no evidence of progressive disease."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 52,
                    "description": "The patient has clinically significant cardiovascular disease (e.g., uncontrolled or any New York Heart Association Class 3 or 4 heart failure (see Appendix 1), uncontrolled angina, history of myocardial infarction, unstable angina or stroke within 6 months prior to study entry, uncontrolled hypertension or clinically significant arrhythmias not controlled by medication)."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 53,
                    "description": "The patient has uncontrolled, clinically significant pulmonary disease (e.g., chronic obstructive pulmonary disease, pulmonary hypertension) that in the opinion of the Investigator would put the patient at significant risk for pulmonary complications during the study."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 54,
                    "description": "The patient has known active or suspected brain or leptomeningeal metastases. Central Nervous System (CNS) imaging is not required prior to study entry unless there is a clinical suspicion of CNS involvement. Patients with stable, treated brain metastases are eligible provided there is no evidence of CNS disease growth on imaging for at least 8 weeks following radiation therapy or other locoregional ablative therapy to the CNS."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 55,
                    "description": "The patient has a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 14 days prior to study therapy administration. Inhaled or topical steroids are permitted in the absence of active autoimmune disease."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 56,
                    "description": "The patient has uncontrolled intercurrent illness including, but not limited to, uncontrolled infection requiring therapy, disseminated intravascular coagulation, or psychiatric illness/social situations that would limit compliance with study requirements."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 57,
                    "description": "The patient is pregnant or breast feeding."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 58,
                    "description": "The patient has known positive status for human immunodeficiency virus or active or chronic Hepatitis B or Hepatitis C."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 59,
                    "description": "The patient is oxygen-dependent."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 60,
                    "description": "The patient has a history of pancreatitis."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 61,
                    "description": "The patient has Grade \u22652 hypercholesterolemia (total cholesterol >300 mg/dL or >7.75 mmol/L) and/or hypertriglyceridemia (triglyceride >300 mg/dL or >3.42 mmol/L) in the fasting state."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 62,
                    "description": "QTcF >450 msec (males) or >470 msec (females)."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 63,
                    "description": "The patient has a physical abnormality or medical condition that limits swallowing multiple pills, or has a history of non-adherence to oral therapies."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 64,
                    "description": "The patient requires statin (e.g., rosuvastatin, atorvastatin, etc.) therapy. If the patient is taking a statin but discontinuation is considered appropriate, the statin must be discontinued at least 5 days prior to starting study therapy."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 65,
                    "description": "The patient requires treatment with a medication that is a strong inhibitor of CYP3A4 (boceprevir, clarithromycin, conivaptan, grapefruit juice, indinavir, itraconazole, ketoconazole, lopinavir/ritonavir, mibefradil, nefazodone, nelfinavir, posaconazole, ritonavir, saquinavir, telaprevir, telithromycin, or voriconazole)."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 66,
                    "description": "For the docetaxel escalation stage, patients with NSCLC with alkaline phosphatase > 2.5 \u00d7 institutional ULN and AST or ALT > 1.5 \u00d7 institutional ULN."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 67,
                    "description": "For patients with NSCLC enrolled in the pembrolizumab plus carboplatin/pemetrexed combination dose escalation or expansion stages:"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 68,
                    "description": "The patient received radiation therapy to the lung that is >30 Gray (Gy) within 6 months of the first dose of study medication"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 69,
                    "description": "The patient completed palliative radiotherapy \u22647 days of the first dose of study medication"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 70,
                    "description": "The patient has received live-virus vaccination \u226430 days of planned start of study medication"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 71,
                    "description": "The patient has clinically active diverticulitis, intra-abdominal abscess, gastrointestinal obstruction, peritoneal carcinomatosis"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 72,
                    "description": "The patient is expected to require any other form of antineoplastic therapy while on study."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 73,
                    "description": "The patient has known hypersensitivity to another monoclonal antibody (mAb)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 74,
                    "description": "The patient has known sensitivity to any component of carboplatin or pemetrexed"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 75,
                    "description": "The patient is unable to interrupt aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), other than an aspirin dose \u22641.3 g per day, for a 5-day period (8-day period for long-acting agents, such as piroxicam)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 76,
                    "description": "The patient is unable or unwilling to take folic acid or vitamin B12 supplementation"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 77,
                    "description": "The patient has clinical or laboratory evidence of a paraneoplastic syndrome."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 78,
                    "description": "The patient has experienced weight loss of >10% of their body weight over the preceding 3 months."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 79,
                    "description": "The patient has any medical condition which, in the opinion of the Investigator, places the patient at an unacceptably high risk for toxicities."
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": null,
        "official_title": "A Phase 1 Study of RGX-104, a Small Molecule LXR Agonist, as a Single Agent and as Combination Therapy in Patients With Advanced Solid Malignancies and Lymphoma With an Expansion in Select Malignancies",
        "_phase_sort_order": 4,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "6 months",
                "name": "Maximum tolerated dose (MTD), or the maximum tested dose at which multiple DLTs are not observed, of RGX-104 as a single agent, and separately, in combination with nivolumab, ipilimumab, docetaxel, or pembrolizumab plus carboplatin/pemetrexed.",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "24 months",
                "name": "Number of participants with treatment-emergent adverse events associated with RGX-104 treatment as a single agent, and separately, in combination with nivolumab, ipilimumab, docetaxel, or pembrolizumab plus carboplatin/pemetrexed.",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "24 months",
                "name": "Overall response rate associated with RGX-104 treatment as a single agent, and separately, in combination with docetaxel or pembrolizumab plus carboplatin/pemetrexed.",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "24 months",
                "name": "Pharmacokinetics: Area Under the Curve (AUC) of RGX-104.",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "24 months",
                "name": "Pharmacokinetics: Maximum Plasma Concentration (Cmax) of RGX-104.",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "24 months",
                "name": "Progression-free survival associated with RGX-104 treatment as a single agent, and separately, in combination with docetaxel or pembrolizumab plus carboplatin/pemetrexed.",
                "description": null,
                "type_code": "PRIMARY"
            }
        ],
        "phase": "I",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 5,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT02922764",
        "biomarkers": [],
        "classification_code": null,
        "current_trial_status_date": "2016-11-01",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Fallopian Tube Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C115429",
                "name": "Recurrent Fallopian Tube Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C3867",
                    "C7620"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Primary Peritoneal Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C115441",
                "name": "Recurrent Primary Peritoneal Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7619",
                    "C40022",
                    "C131500"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "resistant cancer",
                    "Refractory Cancer",
                    "clinical resistance"
                ],
                "nci_thesaurus_concept_id": "C120186",
                "name": "Refractory Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C7628"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Malignant Solid Neoplasm",
                    "Recurrent Solid Neoplasm",
                    "Relapsed Solid Tumor",
                    "Recurrent Solid Tumor",
                    "Relapsed Malignant Solid Neoplasm",
                    "Relapsed Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127153",
                "name": "Recurrent Malignant Solid Tumor",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C132146",
                    "C4813"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Solid Neoplasm",
                    "Metastatic Solid Tumor",
                    "Metastatic Tumor",
                    "Metastatic Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127155",
                "name": "Metastatic Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127156",
                "name": "Unresectable Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Non-Squamous Non-Small Cell Lung Carcinoma",
                    "Metastatic Non-Squamous Non-Small Cell Lung Cancer"
                ],
                "nci_thesaurus_concept_id": "C128798",
                "name": "Metastatic Lung Non-Squamous Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C135017",
                    "C156094"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Locally Advanced Solid Tumor",
                    "Locally Advanced Malignant Solid Neoplasm",
                    "Locally Advanced Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C133093",
                "name": "Locally Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8524",
                    "C127155"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C133737",
                "name": "Refractory Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C120186",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C134154",
                "name": "Refractory Lymphoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3208",
                    "C172280"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C134157",
                "name": "Recurrent Lymphoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C3208",
                    "C172133"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIB",
                    "Stage IIIB Lung Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C136480",
                "name": "Stage IIIB Lung Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C136478"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Lung Cancer AJCC v8",
                    "Stage IV"
                ],
                "nci_thesaurus_concept_id": "C136482",
                "name": "Stage IV Lung Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C136467"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVA Lung Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C136483",
                "name": "Stage IVA Lung Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C136482"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVB Lung Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C136484",
                "name": "Stage IVB Lung Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C136482"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III Ovarian Cancer AJCC v8",
                    "Stage III Ovarian Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139971",
                "name": "Stage III Ovarian Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139963"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIA Ovarian Carcinoma AJCC v8",
                    "Stage IIIA Ovarian Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139972",
                "name": "Stage IIIA Ovarian Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139971"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIA1 Ovarian Cancer AJCC v8",
                    "Stage IIIA1 Ovarian Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139973",
                "name": "Stage IIIA1 Ovarian Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139972"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIA2 Ovarian Carcinoma AJCC v8",
                    "Stage IIIA2 Ovarian Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139974",
                "name": "Stage IIIA2 Ovarian Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139972"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIB Ovarian Cancer AJCC v8",
                    "Stage IIIB Ovarian Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139975",
                "name": "Stage IIIB Ovarian Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139971"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIC Ovarian Cancer AJCC v8",
                    "Stage IIIC Ovarian Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139976",
                "name": "Stage IIIC Ovarian Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139971"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Ovarian Cancer AJCC v8",
                    "Stage IV Ovarian Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139977",
                "name": "Stage IV Ovarian Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139963"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVA Ovarian Carcinoma AJCC v8",
                    "Stage IVA Ovarian Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139978",
                "name": "Stage IVA Ovarian Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139977"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVB Ovarian Carcinoma AJCC v8",
                    "Stage IVB Ovarian Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139979",
                "name": "Stage IVB Ovarian Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139977"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III Fallopian Tube Cancer AJCC v8",
                    "Stage III Fallopian Tube Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139991",
                "name": "Stage III Fallopian Tube Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139983"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIA Fallopian Tube Cancer AJCC v8",
                    "Stage IIIA Fallopian Tube Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139992",
                "name": "Stage IIIA Fallopian Tube Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139991"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIA1 Fallopian Tube Cancer AJCC v8",
                    "Stage IIIA1 Fallopian Tube Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139993",
                "name": "Stage IIIA1 Fallopian Tube Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139992"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIA2 Fallopian Tube Carcinoma AJCC v8",
                    "Stage IIIA2 Fallopian Tube Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139994",
                "name": "Stage IIIA2 Fallopian Tube Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139992"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIB Fallopian Tube Cancer AJCC v8",
                    "Stage IIIB Fallopian Tube Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139995",
                "name": "Stage IIIB Fallopian Tube Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139991"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIC Fallopian Tube Cancer AJCC v8",
                    "Stage IIIC Fallopian Tube Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139996",
                "name": "Stage IIIC Fallopian Tube Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139991"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Fallopian Tube Cancer AJCC v8",
                    "Stage IV Fallopian Tube Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139997",
                "name": "Stage IV Fallopian Tube Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139983"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVA Fallopian Tube Cancer AJCC v8",
                    "Stage IVA Fallopian Tube Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139998",
                "name": "Stage IVA Fallopian Tube Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139997"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVB Fallopian Tube Cancer AJCC v8",
                    "Stage IVB Fallopian Tube Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139999",
                "name": "Stage IVB Fallopian Tube Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139997"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III Primary Peritoneal Carcinoma AJCC v8",
                    "Stage III Primary Peritoneal Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140008",
                "name": "Stage III Primary Peritoneal Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140004"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIA Primary Peritoneal Carcinoma AJCC v8",
                    "Stage IIIA Primary Peritoneal Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140009",
                "name": "Stage IIIA Primary Peritoneal Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140008"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIB Primary Peritoneal Cancer AJCC v8",
                    "Stage IIIB Primary Peritoneal Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140010",
                "name": "Stage IIIB Primary Peritoneal Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140008"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIC Primary Peritoneal Carcinoma AJCC v8",
                    "Stage IIIC Primary Peritoneal Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140011",
                "name": "Stage IIIC Primary Peritoneal Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140008"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Primary Peritoneal Cancer AJCC v8",
                    "Stage IV Primary Peritoneal Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140012",
                "name": "Stage IV Primary Peritoneal Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140004"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVA Primary Peritoneal Cancer AJCC v8",
                    "Stage IVA Primary Peritoneal Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140013",
                "name": "Stage IVA Primary Peritoneal Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140012"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVB Primary Peritoneal Cancer AJCC v8",
                    "Stage IVB Primary Peritoneal Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140014",
                "name": "Stage IVB Primary Peritoneal Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140012"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Non-Squamous Non-Small Cell Lung Carcinoma",
                    "Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C153200",
                "name": "Locally Advanced Non-Squamous Non-Small Cell Lung Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C160783",
                    "C128798"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156485",
                "name": "Metastatic Neuroendocrine Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3809",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C157657",
                "name": "Unresectable Lymphoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3208",
                    "C27359"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C162642",
                "name": "Unresectable Lung Non-Squamous Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C135017",
                    "C155901"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C27359",
                "name": "Unresectable Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrence",
                    "Recurrent Cancer",
                    "Recurrent Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C4813",
                "name": "Recurrent Malignant Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C9305",
                    "C4798"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Oat Cell Lung Carcinoma",
                    "Small Cell Neuroendocrine Carcinoma of the Lung",
                    "Oat Cell Carcinoma of the Lung",
                    "SCLC",
                    "Lung Small Cell Neuroendocrine Carcinoma",
                    "Lung Oat Cell Carcinoma",
                    "Small Cell Carcinoma of Lung",
                    "Lung Small Cell Carcinoma",
                    "Oat Cell Carcinoma of Lung",
                    "Small Cell Carcinoma of the Lung",
                    "Small Cell Neuroendocrine Carcinoma of Lung",
                    "Small Cell Lung Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C4917",
                "name": "Small Cell Lung Cancer",
                "type": [
                    "grade",
                    "maintype",
                    "subtype"
                ],
                "parents": [
                    "C3915",
                    "C45569"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Relapsed Carcinoma of the Ovary",
                    "Relapsed Ovarian Carcinoma",
                    "Relapsed Ovarian Epithelial Cancer",
                    "Recurrent Ovarian Carcinoma",
                    "Recurrent Ovarian Epithelial Cancer",
                    "Recurrent Carcinoma of the Ovary",
                    "Recurrent Epithelial Cancer of Ovary",
                    "Relapsed Epithelial Cancer of Ovary",
                    "Recurrent Epithelial Cancer of the Ovary",
                    "Recurrent Carcinoma of Ovary",
                    "Relapsed Carcinoma of Ovary",
                    "Relapsed Epithelial Cancer of the Ovary"
                ],
                "nci_thesaurus_concept_id": "C7833",
                "name": "Recurrent Ovarian Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7620",
                    "C4908"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Ann Arbor Stage III Lymphoma",
                    "Lymphoma Stage III"
                ],
                "nci_thesaurus_concept_id": "C8320",
                "name": "Stage III Lymphoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C141139"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Lymphoma Stage IV",
                    "Ann Arbor Stage IV Lymphoma"
                ],
                "nci_thesaurus_concept_id": "C8321",
                "name": "Stage IV Lymphoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C141139"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Cancer",
                    "Locally advanced",
                    "regional cancer",
                    "Locally Metastatic Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8524",
                "name": "Locally Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Relapsed Hematologic Malignancy",
                    "Recurrent Hematologic Cancer",
                    "Relapsed Hematologic Cancer",
                    "Recurrent Hematologic Malignancy"
                ],
                "nci_thesaurus_concept_id": "C27358",
                "name": "Recurrent Hematopoietic and Lymphoid Cell Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4813",
                    "C27134"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Lymphoid Neoplasm",
                    "Lymphoid and Plasma Cell Tumor",
                    "Lymphocytic and Plasma Cell Neoplasm",
                    "Lymphoid and Plasmacytic Tumour",
                    "Lymphoid and Plasma Cell Tumour",
                    "Lymphoid and Plasmacytic Tumor",
                    "Lymphoid and Plasmacytic Neoplasm",
                    "Lymphocytic Tumor",
                    "Lymphocytic and Plasmacytic Neoplasm",
                    "Lymphoid Tumor",
                    "Lymphocytic and Plasma Cell Tumor",
                    "Lymphocytic and Plasma Cell Tumour"
                ],
                "nci_thesaurus_concept_id": "C7065",
                "name": "Lymphocytic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9308",
                    "C27134"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Hematopoietic and Lymphoid System Disease"
                ],
                "nci_thesaurus_concept_id": "C35814",
                "name": "Hematopoietic and Lymphoid System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Solid Tumour",
                    "Solid tumor, NOS",
                    "Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C9292",
                "name": "Solid Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Blood Disease",
                    "Blood Disorder",
                    "Hematological Disorder",
                    "Hematologic Disorder"
                ],
                "nci_thesaurus_concept_id": "C26323",
                "name": "Hematologic and Lymphocytic Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C35814"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Hematopoietic Neoplasm",
                    "Hematopoietic Neoplasms Including Lymphomas",
                    "HEMOLYMPHORETICULAR TUMOR, MALIGNANT",
                    "Hematopoietic Cancer",
                    "Hematopoietic and Lymphoid Neoplasm",
                    "Hematologic Cancer",
                    "Hematologic Malignancy",
                    "Hematologic Neoplasm",
                    "Malignant Hematologic Neoplasm",
                    "Hematological Neoplasm",
                    "Hematopoietic malignancy, NOS",
                    "Hematopoietic Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C27134",
                "name": "Hematopoietic and Lymphoid Cell Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C26323",
                    "C35813",
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Recurrence",
                    "Recurrent",
                    "Recurrent Tumor",
                    "Neoplasm Recurrence"
                ],
                "nci_thesaurus_concept_id": "C4798",
                "name": "Recurrent Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C172133",
                "name": "Recurrent Malignant Lymphoid Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C147861",
                    "C7065",
                    "C27358"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Lymphoma, NOS",
                    "Lymphomatous",
                    "Malignant Lymphoma",
                    "Lymphoma (Hodgkin and Non-Hodgkin)",
                    "Lymphoma (Hodgkin's and Non-Hodgkin's)",
                    "LYMPHOMA, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C3208",
                "name": "Lymphoma",
                "type": [
                    "maintype",
                    "subtype"
                ],
                "parents": [
                    "C7065",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Lymphoproliferative disease, NOS",
                    "Lymphoproliferative disorder, NOS"
                ],
                "nci_thesaurus_concept_id": "C9308",
                "name": "Lymphoproliferative Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26323"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C132146",
                "name": "Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C147861",
                "name": "Recurrent Lymphoproliferative Disorder",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C9308"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Hematopoietic and Lymphoid System Tumor"
                ],
                "nci_thesaurus_concept_id": "C35813",
                "name": "Hematopoietic and Lymphoid System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C35814"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor Morphology",
                    "Tumor_Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Thoracic Tumor",
                    "Neoplasm of Thorax",
                    "Tumor of Thorax",
                    "Neoplasm of the Thorax",
                    "Tumor of the Thorax"
                ],
                "nci_thesaurus_concept_id": "C3406",
                "name": "Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C35742"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Tumor of the Lung",
                    "Malignant Neoplasm of Lung",
                    "Malignant Lung Tumor",
                    "Malignant Neoplasm of the Lung",
                    "Malignant Tumor of Lung"
                ],
                "nci_thesaurus_concept_id": "C7377",
                "name": "Malignant Lung Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3576",
                    "C3200",
                    "C4571"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Respiratory and Thoracic Disease",
                    "Respiratory, Thoracic, and Mediastinal Disease",
                    "Respiratory, Thoracic, and Mediastinal Disorder"
                ],
                "nci_thesaurus_concept_id": "C27669",
                "name": "Respiratory and Thoracic Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Lung Carcinoma",
                    "Cancer of the Lung",
                    "Carcinoma of the Lung",
                    "Lung Cancer (all types)",
                    "Lung cancer, NOS",
                    "Carcinoma of Lung",
                    "Cancer of Lung"
                ],
                "nci_thesaurus_concept_id": "C4878",
                "name": "Lung Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2916",
                    "C7377"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Fallopian Tube Disease"
                ],
                "nci_thesaurus_concept_id": "C26771",
                "name": "Fallopian Tube Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27020"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Hematologic Cancer"
                ],
                "nci_thesaurus_concept_id": "C27357",
                "name": "Refractory Hematologic Malignancy",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27134",
                    "C120186"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Endocrine Neoplasm, Malignant",
                    "Endocrine cancer, NOS",
                    "endocrine cancer",
                    "Malignant Endocrine Tumor",
                    "Malignant Neoplasm of the Endocrine Gland",
                    "Malignant Endocrine Gland Neoplasm",
                    "Malignant Tumor of Endocrine Gland",
                    "Malignant Tumor of the Endocrine Gland",
                    "Malignant Neoplasm of Endocrine Gland",
                    "Malignant Endocrine Gland Tumor"
                ],
                "nci_thesaurus_concept_id": "C3575",
                "name": "Malignant Endocrine Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3010",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Malignant Epithelial Neoplasm",
                    "Epithelial Carcinoma",
                    "Malignant Epithelioma",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Epithelial tumor, malignant",
                    "Epithelioma Malignant"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3709",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C157686",
                "name": "Refractory Lymphoproliferative Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9308"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C148130",
                "name": "Locally Advanced Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8524",
                    "C3482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor of Female Reproductive System",
                    "Gynecologic Neoplasm",
                    "Tumor of the Female Reproductive System",
                    "Neoplasm of Female Reproductive System",
                    "Gynecologic Tumor",
                    "Neoplasm of the Female Reproductive System",
                    "Female Reproductive System Tumor"
                ],
                "nci_thesaurus_concept_id": "C3053",
                "name": "Female Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27020",
                    "C3674"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C65151",
                "name": "Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor Stage (Pathological)"
                ],
                "nci_thesaurus_concept_id": "C136467",
                "name": "Lung Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4878"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Cancer of the Peritoneum",
                    "Peritoneal Cancer",
                    "Cancer of Peritoneum",
                    "Peritoneal Cavity Cancer"
                ],
                "nci_thesaurus_concept_id": "C3538",
                "name": "Malignant Peritoneal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156711",
                    "C3322"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor of the Ovary",
                    "Tumor of Ovary",
                    "Neoplasm of Ovary",
                    "Ovarian Neoplasm",
                    "Neoplasm of the Ovary",
                    "Ovarian Tumors"
                ],
                "nci_thesaurus_concept_id": "C4984",
                "name": "Ovarian Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26841",
                    "C3053"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Ovarian Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C139963",
                "name": "Ovarian Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4908"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Genitourinary Disorder",
                    "Urogenital Disease"
                ],
                "nci_thesaurus_concept_id": "C156660",
                "name": "Genitourinary System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Tumor of the Fallopian Tube",
                    "Malignant Neoplasm of Fallopian Tube",
                    "Fallopian Tube Malignant Neoplasm",
                    "Fallopian Tube Malignant Tumor",
                    "Malignant Tumor of Fallopian Tube",
                    "Malignant Fallopian Tube Tumor",
                    "Neoplasm, Fallopian Tube, Malignant",
                    "Malignant Neoplasm of the Fallopian Tube",
                    "Tumor, Fallopian Tube, Malignant"
                ],
                "nci_thesaurus_concept_id": "C7480",
                "name": "Malignant Fallopian Tube Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3032",
                    "C4913"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3322",
                "name": "Peritoneal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26848",
                    "C7337"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Female Reproductive System Cancer"
                ],
                "nci_thesaurus_concept_id": "C7620",
                "name": "Recurrent Female Reproductive System Carcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C150526",
                    "C7619"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Neoplasm of Thorax",
                    "Malignant Tumor of Thorax",
                    "Malignant Neoplasm of the Thorax",
                    "Malignant Tumor of the Thorax",
                    "Malignant Thoracic Tumor"
                ],
                "nci_thesaurus_concept_id": "C3576",
                "name": "Malignant Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3406",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156711",
                "name": "Malignant Peritoneal and Retroperitoneal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C7337"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Tumor"
                ],
                "nci_thesaurus_concept_id": "C7628",
                "name": "Refractory Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Unspecified Respiratory Problem",
                    "Respiratory Disorder",
                    "Disorder of Respiratory System"
                ],
                "nci_thesaurus_concept_id": "C26871",
                "name": "Respiratory System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27669"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Genitourinary Neoplasm",
                    "Genitourinary System Cancer",
                    "Genitourinary Cancer"
                ],
                "nci_thesaurus_concept_id": "C156484",
                "name": "Malignant Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Peritoneal Disease"
                ],
                "nci_thesaurus_concept_id": "C26848",
                "name": "Peritoneal Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27664"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Primary Peritoneal Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C140004",
                "name": "Primary Peritoneal Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C40022"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C155902",
                "name": "Unresectable Lung Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C179420",
                    "C4878",
                    "C148124"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C177724",
                "name": "Recurrent Malignant Genitourinary System Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C156484",
                    "C4813"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "NEC",
                    "Neuroendocrine Carcinoma",
                    "Neuroendocrine cancer, NOS",
                    "Neuroendocrine carcinoma, NOS"
                ],
                "nci_thesaurus_concept_id": "C3773",
                "name": "Neuroendocrine Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C3809",
                    "C3575"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Ovarian cancer, NOS",
                    "Malignant Neoplasm of the Ovary",
                    "Ovarian Cancer",
                    "Malignant Neoplasm of Ovary",
                    "Cancer of Ovary",
                    "Malignant Tumor of the Ovary",
                    "Cancer of the Ovary",
                    "Malignant Tumor of Ovary",
                    "Malignant Ovarian Tumor"
                ],
                "nci_thesaurus_concept_id": "C7431",
                "name": "Malignant Ovarian Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4913",
                    "C4984"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Fallopian Tube Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C139983",
                "name": "Fallopian Tube Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C3867"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Lung Non-Squamous Non-Small Cell Carcinoma",
                    "Non-Squamous Non-Small Cell Lung Carcinoma",
                    "Non-squamous"
                ],
                "nci_thesaurus_concept_id": "C135017",
                "name": "Non-Squamous Non-Small Cell Lung Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2926"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Infrequent Tumor"
                ],
                "nci_thesaurus_concept_id": "C7201",
                "name": "Infrequent Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "PPC",
                    "Primary Peritoneal Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C40022",
                "name": "Primary Peritoneal Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2916",
                    "C3538"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C150526",
                "name": "Recurrent Malignant Female Reproductive System Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C177724",
                    "C4913"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm of Lung",
                    "Tumor of the Lung",
                    "Tumor of Lung",
                    "Lung Tumor",
                    "Lung Neoplasms",
                    "Neoplasm of the Lung"
                ],
                "nci_thesaurus_concept_id": "C3200",
                "name": "Lung Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3406",
                    "C3355",
                    "C3198"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disorder of Lung",
                    "Pulmonary Disease",
                    "Pulmonary Diseases",
                    "Pulmonary Disorders",
                    "Lung Disorders",
                    "Pulmonary Disorder"
                ],
                "nci_thesaurus_concept_id": "C3198",
                "name": "Lung Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26871",
                    "C35742"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36076",
                "name": "Malignant Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C3674"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Oat Cell Cancer",
                    "Oat Cell Carcinoma",
                    "Small Cell Cancer",
                    "Small cell carcinoma, NOS",
                    "Small Cell Neuroendocrine Carcinoma",
                    "Small Cell NEC"
                ],
                "nci_thesaurus_concept_id": "C3915",
                "name": "Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3773"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C176862",
                "name": "Metastatic Malignant Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3576",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Respiratory Tract Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C4571",
                "name": "Malignant Respiratory System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C3355"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Cancer",
                    "Relapsed Carcinoma",
                    "Relapsed Cancer"
                ],
                "nci_thesaurus_concept_id": "C7619",
                "name": "Recurrent Carcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4813",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Endocrine Disease",
                    "Endocrine Disorder",
                    "Thyroid or other glandular disorders",
                    "Disorder of Endocrine System",
                    "Endocrinopathy"
                ],
                "nci_thesaurus_concept_id": "C3009",
                "name": "Endocrine System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Ovarian Surface Epithelial-Stromal Tumor",
                    "Ovarian Surface-Epithelial Stromal Neoplasm",
                    "Epithelial Neoplasm of the Ovary",
                    "Epithelial Neoplasm of Ovary",
                    "Epithelial Tumor of the Ovary",
                    "Epithelial Tumor of Ovary"
                ],
                "nci_thesaurus_concept_id": "C4381",
                "name": "Ovarian Epithelial Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709",
                    "C4984"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C141139",
                "name": "Lymphoma by Ann Arbor Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C27268"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Non-Small Cell Lung Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C155901",
                "name": "Unresectable Lung Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2926",
                    "C155902"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153202",
                "name": "Metastatic Lung Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C4878",
                    "C176862"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156482",
                "name": "Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III",
                    "Stage III Lung Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C136478",
                "name": "Stage III Lung Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C136467"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "High Grade Lung Neuroendocrine Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C45569",
                "name": "Lung Neuroendocrine Carcinoma",
                "type": [
                    "grade",
                    "subtype"
                ],
                "parents": [
                    "C173385",
                    "C4878",
                    "C5670"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Genital Disorders",
                    "Reproductive System Disease",
                    "Disorder of Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C4875",
                "name": "Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C160783",
                "name": "Locally Advanced Lung Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C153206",
                    "C156094"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Reproductive System Tumor",
                    "Neoplasm of Reproductive System",
                    "Reproductive Tumor",
                    "Tumor of the Reproductive System",
                    "Tumor of Reproductive System",
                    "Neoplasm of the Reproductive System",
                    "Reproductive Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C3674",
                "name": "Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156482",
                    "C4875"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C172280",
                "name": "Refractory Malignant Lymphoid Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27357",
                    "C7065",
                    "C157686"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Endocrine System Neoplasm",
                    "Endocrine System Tumor",
                    "Endocrine Tumor"
                ],
                "nci_thesaurus_concept_id": "C3010",
                "name": "Endocrine Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C3709",
                    "C3009"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C148124",
                "name": "Unresectable Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C27359"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156094",
                "name": "Metastatic Lung Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2926",
                    "C165537",
                    "C153202"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Primary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C131500",
                "name": "Recurrent Primary Malignant Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4813"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Pulmonary Neuroendocrine Neoplasm",
                    "Neuroendocrine Neoplasm of Lung",
                    "Neuroendocrine Neoplasm of the Lung"
                ],
                "nci_thesaurus_concept_id": "C5670",
                "name": "Lung Neuroendocrine Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3809",
                    "C3200"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Fallopian Tube Carcinoma",
                    "Cancer of Fallopian Tube",
                    "Carcinoma of the Fallopian Tube",
                    "Cancer of the Fallopian Tube",
                    "Carcinoma of Fallopian Tube"
                ],
                "nci_thesaurus_concept_id": "C3867",
                "name": "Fallopian Tube Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7480",
                    "C181162",
                    "C7201"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Peritoneal and Retroperitoneal Tumor"
                ],
                "nci_thesaurus_concept_id": "C7337",
                "name": "Peritoneal and Retroperitoneal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C27664"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neuroendocrine Neoplasm",
                    "NEN"
                ],
                "nci_thesaurus_concept_id": "C3809",
                "name": "Neuroendocrine Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3010"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Thoracic Disease"
                ],
                "nci_thesaurus_concept_id": "C35742",
                "name": "Thoracic Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27669"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Peritoneal and Retroperitoneal Disease"
                ],
                "nci_thesaurus_concept_id": "C27664",
                "name": "Peritoneal and Retroperitoneal Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Gynecologic Neoplasm",
                    "Gynecologic Cancer",
                    "Female reprod. system cancer, NOS",
                    "Malignant Gynecologic Tumor",
                    "Malignant Tumor of the Female Reproductive System",
                    "Malignant Neoplasm of the Female Reproductive System",
                    "Female reproductive system cancer, NOS",
                    "Malignant Tumor of Female Reproductive System",
                    "Malignant Neoplasm of Female Reproductive System",
                    "Malignant Female Reproductive System Tumor",
                    "Female Reproductive Cancer"
                ],
                "nci_thesaurus_concept_id": "C4913",
                "name": "Malignant Female Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36076",
                    "C3053"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Ovarian Disease"
                ],
                "nci_thesaurus_concept_id": "C26841",
                "name": "Ovarian Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27020"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Ovarian Surface Epithelial-Stromal Tumor",
                    "Ovarian stromal cancer",
                    "Malignant Ovarian Surface Epithelial-Stromal Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C40026",
                "name": "Malignant Ovarian Epithelial Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4381",
                    "C7431"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C164141",
                "name": "Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C173385",
                "name": "Neuroendocrine Carcinoma, Excluding Head and Neck",
                "type": [
                    "grade",
                    "subtype"
                ],
                "parents": [
                    "C3773"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36310",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153206",
                "name": "Locally Advanced Lung Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C153202",
                    "C148130"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Ovarian Epithelial Cancer",
                    "Epithelial Ovarian Cancer",
                    "Ovarian Carcinoma",
                    "Carcinoma of the Ovary",
                    "Carcinoma of Ovary"
                ],
                "nci_thesaurus_concept_id": "C4908",
                "name": "Ovarian Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C181162",
                    "C40026"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm of Fallopian Tube",
                    "Neoplasm of the Fallopian Tube",
                    "Fallopian Tube Tumor",
                    "Tumor of the Fallopian Tube",
                    "Tumor of Fallopian Tube"
                ],
                "nci_thesaurus_concept_id": "C3032",
                "name": "Fallopian Tube Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3053",
                    "C26771"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Female Reproductive System Disease",
                    "Gynecological Disorder"
                ],
                "nci_thesaurus_concept_id": "C27020",
                "name": "Female Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4875"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C181162",
                "name": "Female Reproductive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C164141",
                    "C4913"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Non Small Cell Lung Cancer NOS",
                    "Lung Non-Small Cell Carcinoma",
                    "Non-small cell lung cancer, NOS",
                    "Non-Small Cell Carcinoma of the Lung",
                    "Non-Small Cell Cancer of Lung",
                    "Non-Small Cell Cancer of the Lung",
                    "Non-Small Cell Lung Carcinoma",
                    "NSCLC - Non-Small Cell Lung Cancer",
                    "Non-Small Cell Carcinoma of Lung",
                    "NSCLC"
                ],
                "nci_thesaurus_concept_id": "C2926",
                "name": "Non-Small Cell Lung Cancer",
                "type": [
                    "maintype",
                    "subtype"
                ],
                "parents": [
                    "C65151",
                    "C4878"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C165537",
                "name": "Metastatic Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C65151",
                    "C3482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C179420",
                "name": "Unresectable Malignant Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3576",
                    "C27359"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C27268",
                "name": "Lymphoma by Stage",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3208"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Respiratory Tract Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C3355",
                "name": "Respiratory System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C26871"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "RGX-104-001",
        "active_sites_count": 7,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Yervoy"
                        ],
                        "nci_thesaurus_concept_id": "C2654",
                        "name": "Ipilimumab",
                        "description": "A monoclonal antibody directed against cytotoxic T-lymphocyte-associated antigen-4 (CTLA4), an antigen that is expressed on activated T-cells and exhibits affinity for B7 co-stimulatory molecules. By binding CTLA4, ipilimumab enhances T-cell activation and blocks B7-1 and B7-2 T-cell co-stimulatory pathways. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C129822",
                            "C128036"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Biological Agent",
                            "Anticancer Biological",
                            "Antineoplastic Biotherapeutic",
                            "Antineoplastic Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-CTLA4 Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C128036",
                        "name": "Anti-CTLA-4 Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C20401",
                            "C141144",
                            "C163758"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C143250",
                        "name": "Immune Checkpoint Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C141144"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C131910",
                        "name": "Abequolixron",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastics",
                            "Anti-Cancer Agents",
                            "Antiproliferative Drugs",
                            "Anti-Tumor Drugs",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Tumor Agents",
                            "Antiproliferative Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Cancer Drug",
                            "Antineoplastic Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastics",
                            "Anti-Cancer Agents",
                            "Antiproliferative Drugs",
                            "Anti-Tumor Drugs",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Tumor Agents",
                            "Antiproliferative Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Cancer Drug",
                            "Antineoplastic Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Pemfexy"
                        ],
                        "nci_thesaurus_concept_id": "C61614",
                        "name": "Pemetrexed",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2021",
                            "C511"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibody",
                            "Monoclonal Antibodies"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C307",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Docecad",
                            "Taxotere Injection Concentrate",
                            "Taxotere"
                        ],
                        "nci_thesaurus_concept_id": "C1526",
                        "name": "Docetaxel",
                        "description": "A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree Taxus baccata.  Docetaxel displays potent and broad antineoplastic properties; it binds to and stabilizes tubulin, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and cell death.  This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and displays immunomodulatory and pro-inflammatory properties by inducing various mediators of the inflammatory response.  Docetaxel has been studied for use as a radiation-sensitizing agent. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C67437",
                            "C1490"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C718",
                        "name": "Organic Chemical",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1913"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug",
                            "Pharmaceuticals",
                            "Drug Substance",
                            "Agent",
                            "Pharmacological Substance",
                            "Pharmaceutical Agent",
                            "Pharmacologic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hydrocarbons"
                        ],
                        "nci_thesaurus_concept_id": "C552",
                        "name": "Hydrocarbon",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C718"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Taxanes"
                        ],
                        "nci_thesaurus_concept_id": "C1490",
                        "name": "Taxane Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C860"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Mitotic Inhibitors",
                            "Mitosis Inhibitor Drugs",
                            "Antimitotic Drugs",
                            "Mitosis Inhibitor Agents",
                            "Microtubular Function Inhibitors",
                            "Mitotic Inhibitor Drugs",
                            "Mitosis Inhibitors",
                            "Mitotic Inhibitor Agents",
                            "Antimitotics"
                        ],
                        "nci_thesaurus_concept_id": "C273",
                        "name": "Antimitotic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1913",
                        "name": "Drug or Chemical by Structure",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2163",
                        "name": "DNA Adduct Forming Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2842"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-PD-1 Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C128037",
                        "name": "Anti-PD1 Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C124946",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immune Mediators",
                            "Immunomodulatory Agent",
                            "Biological Response Modifier",
                            "BRM",
                            "Immune Modulators",
                            "Biomodulators",
                            "Immunotherapeutic Agent",
                            "Immunotherapy Agent",
                            "Immunomodulators",
                            "Immunomodulating Agent",
                            "Immune Regulators",
                            "Immunopotentiators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biologicals",
                            "Biological Products",
                            "Biologics",
                            "Immunologics",
                            "Biopharmaceuticals",
                            "Immunologic, Immunochemical"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2842",
                        "name": "DNA Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antimetabolites"
                        ],
                        "nci_thesaurus_concept_id": "C272",
                        "name": "Antimetabolite",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "PD-1 Inhibitor",
                            "PD-1-targeting Agent",
                            "Protein PD-1 Inhibitor",
                            "Programmed Cell Death Protein 1 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C124946",
                        "name": "PD1 Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C143250"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Antineoplastic Ab",
                            "Anticancer Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immune Mediators",
                            "Immunomodulatory Agent",
                            "Biological Response Modifier",
                            "BRM",
                            "Immune Modulators",
                            "Biomodulators",
                            "Immunotherapeutic Agent",
                            "Immunotherapy Agent",
                            "Immunomodulators",
                            "Immunomodulating Agent",
                            "Immune Regulators",
                            "Immunopotentiators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Thymidylate Synthetase Inhibitors"
                        ],
                        "nci_thesaurus_concept_id": "C2021",
                        "name": "Thymidylate Synthase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Terpenes"
                        ],
                        "nci_thesaurus_concept_id": "C860",
                        "name": "Terpene Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C552",
                            "C616"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Chemotherapy Alkylating Agents",
                            "Chemotherapy Alkylators"
                        ],
                        "nci_thesaurus_concept_id": "C1590",
                        "name": "Antineoplastic Alkylating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2842"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Taxane-Site Binding Agent"
                        ],
                        "nci_thesaurus_concept_id": "C67437",
                        "name": "Taxane-Pocket Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C25974"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Immunotherapeutic",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Biological Response Modifier",
                            "Antineoplastic BRM"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Radiosensitizers",
                            "Radiation Sensitizers",
                            "Radiation-Sensitizing Drugs",
                            "Radiation-Sensitizing Agents",
                            "Radiosensitizing Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C798",
                        "name": "Radiosensitizing Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Platinum Agents",
                            "Platinum-Based Chemotherapy"
                        ],
                        "nci_thesaurus_concept_id": "C1450",
                        "name": "Platinum Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2163",
                            "C1590",
                            "C798"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Folic Acid Inhibitors",
                            "Folic Acid Antagonists",
                            "Folic Acid Antagonist",
                            "Folate Analog",
                            "Folate Inhibitors",
                            "Antifolates",
                            "Folic Acid Analog"
                        ],
                        "nci_thesaurus_concept_id": "C511",
                        "name": "Folate Antagonist",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C272"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Opdivo"
                        ],
                        "nci_thesaurus_concept_id": "C68814",
                        "name": "Nivolumab",
                        "description": "A fully human monoclonal antibody directed against  the  negative immunoregulatory human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1/PCD-1) with immunopotentiation activity.  Nivolumab binds to and blocks the activation of PD-1, an Ig superfamily transmembrane protein, by its ligands PD-L1 and PD-L2, resulting in the activation of T-cells and cell-mediated  immune responses against tumor cells or pathogens. Activated PD-1 negatively regulates T-cell activation and effector function through the suppression of P13k/Akt pathway activation.  Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C128037",
                            "C129822"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Keytruda"
                        ],
                        "nci_thesaurus_concept_id": "C106432",
                        "name": "Pembrolizumab",
                        "description": "A humanized monoclonal IgG4 antibody directed against human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1) with potential immunopotentiating activity. Upon administration, pembrolizumab binds to PD-1, an inhibitory signaling receptor expressed on the surface of activated T cells, and blocks the binding to and activation of PD-1 by its ligands, which results in the activation of T-cell-mediated immune responses against tumor cells. The ligands for PD-1 include PD-L1, which is expressed on antigen presenting cells (APCs) and overexpressed on certain cancer cells, and PD-L2, which is primarily expressed on APCs. Activated PD-1 negatively regulates T-cell activation through the suppression of the PI3K/Akt pathway. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C128037"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Tubulin Binding Agents"
                        ],
                        "nci_thesaurus_concept_id": "C25974",
                        "name": "Tubulin Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C273"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug",
                            "Pharmaceuticals",
                            "Drug Substance",
                            "Agent",
                            "Pharmacological Substance",
                            "Pharmaceutical Agent",
                            "Pharmacologic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Molecularly Targeted Therapy Agent",
                            "Targeted Therapeutic Agent",
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Lipids"
                        ],
                        "nci_thesaurus_concept_id": "C616",
                        "name": "Lipid",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C718"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Carbosol",
                            "Displata",
                            "Carboplat",
                            "Nealorin",
                            "Paraplatin AQ",
                            "Blastocarb",
                            "Ercar",
                            "Novoplatinum",
                            "Platinwas",
                            "Carbosin",
                            "Ribocarbo",
                            "Carbotec",
                            "Paraplatine"
                        ],
                        "nci_thesaurus_concept_id": "C1282",
                        "name": "Carboplatin",
                        "description": "A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1450"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent",
                            "Enzyme Inhibitor Drug"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "RGX-104 combined with docetaxel",
                "description": "RGX-104 is a small molecule agonist of the liver X receptor (LXR), a member of the nuclear receptor family of transcription factors. Docetaxel is an anti-mitotic chemotherapy that binds to microtubules, blocking mitosis by inhibiting mitotic spindle assembly.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "RGX-104 combined with ipilimumab",
                "description": "RGX-104 is a small molecule agonist of the liver X receptor (LXR), a member of the nuclear receptor family of transcription factors. Ipilimumab is a recombinant human monoclonal antibody that binds to the cytotoxic T-lymphocyte-associated protetin 4 (CTLA-4).",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "RGX-104 combined with nivolumab",
                "description": "RGX-104 is a small molecule agonist of the liver X receptor (LXR), a member of the nuclear receptor family of transcription factors. Nivolumab is a human monoclonal antibody that blocks the interaction between PD-1 and its ligands, PDL1 and PD-L2.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "RGX-104 combined with pembrolizumab and carboplatin/pemetrexed",
                "description": "RGX-104 is a small molecule agonist of the liver X receptor (LXR), a member of the nuclear receptor family of transcription factors. Pembrolizumab is a humanized monoclonal antibody that binds to the PD-1 receptor and blocks its interaction with PD-L1 and PD-L2. Carboplatin is a platinum compound alkylating agent which covalently binds to DNA; interferes with the function of DNA by producing interstrand DNA cross-links. Pemetrexed is an antifolate, disrupting folate-dependent metabolic processes essential for cell replication.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Single agent RGX-104",
                "description": "RGX-104 is a small molecule agonist of the liver X receptor (LXR), a member of the nuclear receptor family of transcription factors.",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2017-00226",
        "why_study_stopped": null,
        "brief_summary": "Study RGX-104-001 is a Phase 1, first-in-human, dose escalation and expansion study of\r\n      RGX-104, an oral small molecule targeting the liver X receptor (LXR), as a single agent and\r\n      in combination with nivolumab, ipilimumab, docetaxel, or pembrolizumab plus\r\n      carboplatin/pemetrexed. RGX-104 activates LXR, resulting in depletion of both myeloid-derived\r\n      suppressor cells (MDSCs) as well as tumor blood vessels. MDSCs block the ability of T-cells\r\n      and other cells of the immune system from attacking tumors.\r\n\r\n      During the dose escalation stage, multiple doses and schedules of orally administered RGX-104\r\n      with or without nivolumab, ipilimumab, docetaxel, or pembrolizumab plus\r\n      carboplatin/pemetrexed (single agent or combination therapy) will be evaluated in patients\r\n      with advanced solid tumors and lymphoma (i.e., locally advanced and unresectable, or\r\n      metastatic) who have had progressive disease (PD) on available standard systemic therapies or\r\n      for which there are no standard systemic therapies of relevant impact. Dose escalation in\r\n      combination with pembrolizumab plus carboplatin/pemetrexed will be restricted to patients\r\n      with non-small cell lung cancer (NSCLC).\r\n\r\n      In the expansion stage of the study, additional patients with epithelial ovarian carcinoma\r\n      (EOC), NSCLC, or small cell lung cancer (SCLC)/high-grade neuroendocrine tumors (HG-NET) will\r\n      be treated at the MTD (or maximum tested dose if no MTD is identified, or dose below the MTD\r\n      if there is evidence suggesting a more favorable risk/benefit profile). This stage will\r\n      provide further characterization of the safety, efficacy, PK, and pharmacodynamics, including\r\n      biomarkers of immunologic activity and LXR target activation, of RGX-104 as a single agent\r\n      (EOC), in combination with docetaxel (SCLC/HG-NET), and and in combination with pembrolizumab\r\n      plus carboplatin/pemetrexed (NSCLC).",
        "brief_title": "A Study of RGX-104 in Patients With Advanced Solid Malignancies and Lymphoma",
        "status_history": [
            {
                "status_date": "2016-11-01T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 135,
        "_current_trial_status_sort_order": 0,
        "start_date": "2016-11-01",
        "record_verification_date": "2021-10-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Non-Randomized Trial"
        },
        "acronym": null,
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2022-03-01",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]